Trevi Therapeutics, Inc. SEC filings TRVI
Trevi Therapeutics, Inc. has 537 filings in SEC EDGAR's recent list, going back to Dec 18, 2012. Its latest annual report, Form ARS, was filed on Apr 21, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 6, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Aug 6, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Results of operations
|
Aug 6, 2026 | Aug 6, 2026 |
| 8-K |
Current report
Bylaw or fiscal year change, Shareholder vote results
|
Jun 4, 2026 | Jun 3, 2026 |
| 8-K |
Current report
Results of operations
|
May 5, 2026 | May 5, 2026 |
| 8-K |
Current report
Material agreement, Results of operations, Other events
|
Apr 17, 2026 | Apr 16, 2026 |
| 8-K |
Current report
Results of operations
|
Mar 17, 2026 | Mar 17, 2026 |
| 8-K |
Current report
Other events
|
Mar 9, 2026 | Mar 9, 2026 |
| 8-K |
Current report
Officer or director change
|
Dec 5, 2025 | Dec 1, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 13, 2025 | Nov 13, 2025 |
| 8-K |
Current report
Officer or director change
|
Aug 20, 2025 | Aug 14, 2025 |
| 8-K |
Current report
Results of operations
|
Aug 7, 2025 | Aug 7, 2025 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Jun 17, 2025 | Jun 11, 2025 |
| 8-K |
Current report
Material agreement, Other events
|
Jun 4, 2025 | Jun 3, 2025 |
| 8-K |
Current report
Other events
|
Jun 2, 2025 | Jun 2, 2025 |
| 8-K |
Current report
Other events
|
Jun 2, 2025 | Jun 2, 2025 |
| 8-K |
Current report
Results of operations
|
May 8, 2025 | May 8, 2025 |
| 8-K |
Current report
Results of operations
|
Mar 18, 2025 | Mar 18, 2025 |
| 8-K |
Current report
Other events
|
Mar 10, 2025 | Mar 10, 2025 |
| 8-K |
Current report
Results of operations, Other events
|
Jan 8, 2025 | Jan 8, 2025 |
| 8-K |
Current report
Material agreement, Other events
|
Dec 16, 2024 | Dec 15, 2024 |
| 8-K |
Current report
Other events
|
Dec 12, 2024 | Dec 12, 2024 |
| 8-K |
Current report
Other events
|
Dec 3, 2024 | Dec 3, 2024 |
| 8-K |
Current report
Results of operations
|
Nov 6, 2024 | Nov 6, 2024 |
| 8-K |
Current report
Other events
|
Oct 21, 2024 | Oct 21, 2024 |
| 8-K |
Current report
Other events
|
Oct 4, 2024 | Oct 3, 2024 |
| 8-K |
Current report
Officer or director change
|
Oct 1, 2024 | Sep 27, 2024 |
| 8-K |
Current report
Results of operations
|
Aug 8, 2024 | Aug 8, 2024 |
| 8-K |
Current report
Shareholder vote results
|
Jun 13, 2024 | Jun 13, 2024 |
| 8-K |
Current report
Results of operations
|
May 7, 2024 | May 7, 2024 |
| 8-K |
Current report
Results of operations
|
Mar 20, 2024 | Mar 20, 2024 |
| 8-K |
Current report
Results of operations
|
Nov 9, 2023 | Nov 9, 2023 |
| 8-K |
Current report
Results of operations
|
Aug 10, 2023 | Aug 10, 2023 |
| 8-K |
Current report
Bylaw or fiscal year change, Shareholder vote results
|
Jun 29, 2023 | Jun 28, 2023 |
| 8-K |
Current report
Results of operations
|
May 11, 2023 | May 11, 2023 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Apr 14, 2023 | Apr 13, 2023 |
| 8-K |
Current report
Results of operations
|
Mar 16, 2023 | Mar 16, 2023 |
| 8-K |
Current report
Results of operations
|
Nov 10, 2022 | Nov 10, 2022 |
| 8-K |
Current report
Material agreement, Other events
|
Sep 23, 2022 | Sep 22, 2022 |
| 8-K |
Current report
Other events
|
Sep 19, 2022 | Sep 19, 2022 |
| 8-K |
Current report
Results of operations
|
Aug 11, 2022 | Aug 11, 2022 |
| 8-K |
Current report
Other events
|
Jun 29, 2022 | Jun 29, 2022 |
| 8-K |
Current report
Shareholder vote results
|
Jun 23, 2022 | Jun 23, 2022 |
| 8-K |
Current report
Material agreement
|
May 16, 2022 | May 13, 2022 |
| 8-K |
Current report
Results of operations
|
May 12, 2022 | May 12, 2022 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Other events
|
Apr 7, 2022 | Apr 6, 2022 |
| 8-K |
Current report
Results of operations
|
Mar 17, 2022 | Mar 17, 2022 |
| 8-K |
Current report
Other events
|
Mar 16, 2022 | Mar 16, 2022 |
| 8-K |
Current report
Other events
|
Feb 24, 2022 | Feb 24, 2022 |
| 8-K |
Current report
Other events
|
Feb 1, 2022 | Feb 1, 2022 |
| 8-K |
Current report
Listing notice
|
Jan 14, 2022 | Jan 10, 2022 |
| 8-K |
Current report
Other events
|
Jan 5, 2022 | Jan 5, 2022 |
| 8-K |
Current report
Results of operations
|
Nov 10, 2021 | Nov 10, 2021 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Other events
|
Oct 19, 2021 | Oct 15, 2021 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Other events
|
Oct 1, 2021 | Sep 30, 2021 |
| 8-K |
Current report
Results of operations
|
Aug 12, 2021 | Aug 12, 2021 |
| 8-K |
Current report
Shareholder vote results
|
Aug 9, 2021 | Aug 9, 2021 |
| 8-K |
Current report
Other events
|
Jul 9, 2021 | Jul 9, 2021 |
| 8-K |
Current report
Material agreement
|
Jul 7, 2021 | Jul 6, 2021 |
| 8-K |
Current report
Shareholder vote results
|
Jun 21, 2021 | Jun 16, 2021 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Jun 21, 2021 | Jun 18, 2021 |
| 8-K |
Current report
Results of operations
|
May 13, 2021 | May 13, 2021 |
| 8-K |
Current report
Officer or director change
|
Apr 2, 2021 | Mar 29, 2021 |
| 8-K |
Current report
Results of operations
|
Mar 25, 2021 | Mar 25, 2021 |
| 8-K |
Current report
Officer or director change
|
Mar 22, 2021 | Mar 18, 2021 |
| 8-K |
Current report
Results of operations
|
Nov 12, 2020 | Nov 11, 2020 |
| 8-K |
Current report
Other events
|
Oct 21, 2020 | Oct 21, 2020 |
| 8-K |
Current report
Officer or director change
|
Sep 11, 2020 | Sep 8, 2020 |
| 8-K |
Current report
Results of operations
|
Aug 13, 2020 | Aug 13, 2020 |
| 8-K |
Current report
Other events
|
Jul 13, 2020 | Jul 13, 2020 |
| 8-K |
Current report
Officer or director change
|
Jun 30, 2020 | Jun 29, 2020 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Jun 17, 2020 | Jun 11, 2020 |
| 8-K |
Current report
Results of operations
|
May 7, 2020 | May 7, 2020 |
| 8-K |
Current report
Results of operations
|
Mar 16, 2020 | Mar 16, 2020 |
| 8-K |
Current report
Officer or director change
|
Feb 18, 2020 | Feb 13, 2020 |
| 8-K |
Current report
Officer or director change
|
Jan 6, 2020 | Dec 31, 2019 |
| 8-K |
Current report
Results of operations
|
Nov 14, 2019 | Nov 14, 2019 |
| 8-K |
Current report
Officer or director change
|
Sep 24, 2019 | Sep 18, 2019 |
| 8-K |
Current report
Results of operations
|
Aug 12, 2019 | Aug 12, 2019 |
| 8-K |
Current report
Officer or director change
|
Jul 2, 2019 | Jun 28, 2019 |
| 8-K |
Current report
Results of operations
|
Jun 14, 2019 | Jun 13, 2019 |
| 8-K |
Current report
Bylaw or fiscal year change
|
May 9, 2019 | May 9, 2019 |
Showing 80 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- TRVI (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- New Haven, CT
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1563880
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.